Belimumab trials for Lupus

All Belimumab trials · All Lupus trials

Phase breakdown

Recruiting trials studying Belimumab for Lupus

• A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus
  NCT06857214 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
  NCT06576271 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 28 locations
• Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
  NCT07138898 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
  NCT07340463 · Phase: Phase 2 · Ages: 14 Years to 65 Years · Sex: All (male and female) · 1 location
• Trial of Belimumab in Early Lupus
  NCT03543839 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Belimumab for Lupus?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.